# hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)

> **NCT05052957** · PHASE2 · RECRUITING · sponsor: **Leland Metheny** · enrollment: 16 (estimated)

## Conditions studied

- Glioblastoma Multiforme
- Glioblastoma Multiforme, Adult
- Supratentorial Glioblastoma
- Supratentorial Gliosarcoma

## Interventions

- **BIOLOGICAL:** P140K-MGMT
- **DRUG:** O6-benzylguanine
- **RADIATION:** Photon Based Radiotherapy
- **DRUG:** temozolomide
- **DRUG:** Filgrastim
- **DRUG:** carmustine

## Key facts

- **NCT ID:** NCT05052957
- **Lead sponsor:** Leland Metheny
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-20
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2025-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05052957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05052957, "hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05052957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*